Formulation and development of extended-release micro particulate drug delivery system of solubilized rifaximin

AAPS PharmSciTech

Volumn 14, Issue 2, 2013, Pages 639-648

  Karanje, Rohan V ^a   Bhavsar, Yogita V ^a   Jahagirdar, Kirti H ^a   Bhise, Kiran S ^a  

^a Allana College of Pharmacy   (India)

Author keywords

eudragit L100; Key word: cyclodextrin complexes; micro particles; rifaximin; spray dryer

Indexed keywords

BETA CYCLODEXTRIN; EUDRAGIT; RIFAXIMIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; ENTERIC COATED TABLET; IN VITRO STUDY; INFRARED SPECTROSCOPY; PH; PRIORITY JOURNAL; SPRAY DRYING; STOICHIOMETRY; X RAY DIFFRACTION;

ANTI-BACTERIAL AGENTS; BACTERIA; BETA-CYCLODEXTRINS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CRYSTALLOGRAPHY, X-RAY; DELAYED-ACTION PREPARATIONS; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG CARRIERS; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; POLYMETHACRYLIC ACIDS; POWDER DIFFRACTION; RIFAMYCINS; SOLUBILITY; SOLVENTS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TECHNOLOGY, PHARMACEUTICAL;

EID: 84879087138     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-013-9949-x     Document Type: Article

References (20)

1. Martini S et al. Solution structure of rifaximin and its synthetic derivative rifaximin determined by experimental NMR and theoretical simulation methods. Bioorg Med Chem. 2004;12(9):2163-72. doi: 10.1016/j.bmc.2004.02.027.
2. Huang DB, DuPont HL. Rifaximin - a novel antimicrobial for enteric infections. J Infect. 50(2): 97-106.
3. Jahagirdar HA. Patent Application No- 20090028940 USPC CLASS: 424468 NO DOI FOR PATENT.
4. Scarpignato C, Pelosini I. Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential. Chemotherapy. 2005;51 suppl 1:36-66. doi: 10.1159/000081990.
5. Vaira D. Rifaximin suspension for the eradication of Helicobacter pylori. Curr Ther Res. 58(5):300-308.
6. Darkoh C et al. Bile acids improve the antimicrobial effect of rifaximin. Antimicrob agents chemother. 2010;3618-3624. doi: 10.1128/AAC.00161-10.
7. Rawat S, Jain SK. Solubility enhancement of celecoxib using β-cyclodextrin inclusion complexes. Eur J Pharm Biopharm. 2004;57:263-7. doi: 10.1016/j.ejpb.2003.10.020.
8. Bidyut N, Amrutansu P, Annapurna MM. Spectrophotometric estimation of rifaximin in pure and tablet dosage form. Int J Pharm Technol. 2010;2(4):1098-104.
9. Loftsson T, Vogensen SB, Desbos C, Jansook P. Carvedilol: solubilization and cyclodextrin complexation: a technical note. AAPS PharmSciTech. 2008;9(2) (# 2008). doi: 10.1208/s12249-008-9055-7.
10. Patel AR, Vavia PR. Preparation and evaluation of taste masked famotidine formulation using drug/β-cyclodextrin/polymer ternary complexation approach. AAPS PharmSciTech. 2008;9(2):544-50. doi: 10.1208/s12249-008-9078-0.
11. Waleczeka KJ, Cabral Marquesb HM, Hempelc B, Schmidt PC. Phase solubility studies of pure (2)-a-bisabolol and camomile essential oil with b-cyclodextrin. Eur J Pharm Biopharm. 2003;55(2):247-51. doi: 10.1016/S0939-6411(02)00166-2.
12. Hirayama F, Uekama K. Cyclodextrin-based controlled drug release system. Adv Drug Deliv Rev. 1999;36:125-41. doi: 10.1016/S0169-409X(98)00058-1.
13. Liu L et al. A study on the supramolecular structure of inclusion complex of β-cyclodextrin with prazosin hydrachloride. Carbohydrate polymers, 68(Issue 3):472-476. doi: 10.1016/j.carbpol.2006.11.007.
14. Werner F, Okemo P, Ansorg R. Antibacterial activity of East African Medicinal; plants. J Ethnopharmacol. 60:79-84.
15. Alanazi FK, El-Badry M, Ahmed MO, Alsarra IA. Improvement of albendazole dissolution by preparing microparticles using spray-drying technique. Sci Pharm. 2007;75:63-79.
16. Liu W, Wu WD, Selomulya C, Chen XD. Uniform chitosan microparticles prepared by a novel spray-drying technique. Int J Chem Eng. 2011;2011. doi: 10.1155/2011/267218. Article ID 267218, 7 Pages.
17. Robinson S. (Melton Mowbray GB), Smith, Susan Stewart (Leicestershire GB). Spray-drying process for the preparation of microparticles; Application Number: 09/342356 Patent no: US 6,451,349 B1.
18. Elshafeey AH, Sami EI. Preparation and in-vivo pharmacokinetic study of a novel extended release compression coated tablets of Fenoterol Hydrobromide. AAPS PharmSciTech. 2008;9(3) (# 2008). doi: 10.1208/s12249-008-9135-8.
19. Narayan P, Marchant D, Wheatley MA. Optimization of spray drying by factorial design for production of hollow microspheres for ultrasound imaging. J Biomed Mater Res. 2001;56(3):333-41. doi: 10.1002/1097-4636(20010905)56:3333:: AID-JBM1101>3.0.CO;2-K.
20. Tajber L, Corrigan OI, Healy AM. Spray drying of budesonide, formoterol fumarate and their composites - II. Statistical factorial design and in vitro deposition properties. Int J Pharm. 2009;367(1-2):86-96. doi: 10.1016/j.ijpharm.2008.09.029.